CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
Saved in:
| Hovedforfatter: | |
|---|---|
| Publication Date: | 2019 |
| Andre forfattere: | , , , , |
| Format: | Article |
| Sprog: | eng |
| Source: | Repositório Institucional da UnB |
| Download full: | https://repositorio.unb.br/handle/10482/36277 https://doi.org/10.1590/1414-431x20187784 |
Summary: | Myelofibrosis (MF) is characterized by increased circulating hematopoietic progenitor cells (HPCs), abnormal cytokine levels, and the survival advantage of neoplastic progenitors over their normal counterparts, which leads to progressive disappearance of polyclonal hematopoiesis. CD47 is a surface glycoprotein with many functions, such as acting as a phagocytosis inhibitor of the expressing cell, that is increased in normal hematopoietic stem and progenitor cells mobilized into the blood and several human cancer-initiating cells, such as in acute myeloid leukemia. We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. Exposure of control HPCs to the cytokines transforming growth factor β and stromal-derived factor 1, which are important regulators of hematopoietic stem cell cycling and are overexpressed in patients with MF, did not modulate CD47 expression. |
Lignende værker: CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
- Expression of CD90 and P75NTR stem cell markers in ameloblastomas : a possible role in their biological behavior
- Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cells
- Estudo in vitro da função de CD90 em células-tronco tumorais de glioblastoma
- A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells
- Avaliação da ablação de CD90 em células primárias de glioblastomas humanos in vitro
- Regulatory T-Cell enhancement, expression of adhesion molecules, and production of anti-inflammatory factors are differentially modulated by spheroid-cultured mesenchymal stem cells